Stay updated with breaking news from Abby Berger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
First group of healthy volunteers dosed in company's phase I trial of novel non-hallucinogenic psychoplastogen with no psychotomimetic effects
/PRNewswire/ -- Delix Therapeutics (the "Company"), a neuroscience company developing novel disease-modifying, neuroplasticity-promoting therapeutics for...
/PRNewswire/ -- Delix Therapeutics (the "Company"), a neuroscience company developing novel neuroplasticity-promoting therapeutics for psychiatric and...
/PRNewswire/ -- Delix Therapeutics (the "Company"), a neuroscience company developing novel disease-modifying therapeutics for psychiatric and neurological...
/PRNewswire/ -- Delix Therapeutics (the "Company"), a neuroscience company developing novel disease-modifying therapeutics for psychiatric and neurological...